Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-epha4 antibody

An antibody and variable technology, applied in the direction of antibody, anti-enzyme immunoglobulin, recombinant DNA technology, etc., can solve the problem of no antibody report

Active Publication Date: 2020-06-23
EISIA R&D MANAGEMENT CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are no reports on antibodies with neutralizing activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-epha4 antibody
  • Anti-epha4 antibody
  • Anti-epha4 antibody

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0438] Example 1: Preparation of anti-mouse EphA4 monoclonal antibody

[0439] Preparation of mouse anti-mouse EphA4 monoclonal antibody

[0440] In order to prepare a monoclonal antibody that binds to mouse EphA4 (GenBank accession number NP_031962.2, SEQ ID NO: 1), the extracellular region (20 to 547) of mouse EphA4 (SEQ ID NO: 1) was prepared by the following steps. ID NO: 2) A protein fused with secreted alkaline phosphatase (SEAP) and a histidine tag (hereinafter referred to as "mouse EphA4 extracellular region-SEAP-His protein", SEQ ID NO: 43).

[0441] First, using total RNA derived from mouse brain, the DNA sequence encoding the signal sequence (SEQ ID NO: 42) and extracellular region (SEQ ID NO: 2) of mouse EphA4 was amplified by RT-PCR, and cloned to the SalI / NotI sites of the pENTR1A vector (Invitrogen / Life Technologies) with the DNA sequence encoding SEAP and histidine tag. Secondly, the signal sequence, extracellular region, SEAP, and histidine tag DNA seque...

example 2

[0460] Example 2: Binding affinity of anti-EphA4 monoclonal antibodies against mouse and human EphA4

[0461] The binding affinity of antibody A obtained in Example 1 to mouse and human EphA4 was determined by surface plasmon resonance (SPR method) using Biacore A100 (GE Healthcare). First, mouse IgG will be used 1 Rat anti-mouse IgG prepared by immunizing the antibody against rats by common methods 1 Antibodies were immobilized on the sensor chip CM5. rat anti-mouse IgG 1 Antibody immobilization on the sensor chip CM5 was achieved by using N-hydroxysuccinimide (NHS) and N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) was carried out by the amine coupling method, and ethanolamine was used for blocking (both the sensor chip and the immobilization reagent were manufactured by GE Healthcare). Use fixation buffer (10 mM sodium acetate, pH 4.5), dilute to 1 to 2 μg / mL, and immobilize on the sensor chip according to the operation instructions attached to Bi...

example 3

[0463] Example 3: Mouse EphA4-Mouse Ligand Binding Inhibitory Activity of Anti-EphA4 Monoclonal Antibodies

[0464] For antibody A obtained in Example 1, the evaluation of the binding inhibitory activity of mouse EphA4 to the mouse ligand was carried out according to the following procedure. Anti-alkaline phosphatase antibody (Thermo Fisher Scientific) was coated on the wells of a 96-well culture plate (Nunc). After overnight incubation at 4°C, the wells were blocked with 1% Block Ace (DS Pharma Biomedical) for 1 hour at room temperature. After washing 3 times with 0.05% Tween 20 / PBS (Thermo Fisher Scientific), the mouse EphA4 extracellular region-SEAP-His protein (final concentration 10 nM) obtained in the method of Example 1 was added to the well, and incubated at room temperature 1 hour. After washing 3 times, ligands and serially diluted antibody A (0, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100, 300, and 1000 nM) were added to the wells as KYL peptide (KYLP...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An anti-Epha4 antibody. The invention provides an anti-EphA4 antibody or an EphA4-binding fragment thereof which is capable of binding to EphA4 and inhibiting the binding between EphA4 and its ligand,and a pharmaceutical composition comprising the anti-EphA4 antibody or the EphA4-binding fragment thereof as an active ingredient. A mouse anti-EphA4 antibody having binding affinity for EphA4 was obtained, and the sequences of complementarity-determining regions (CDRs) of the mouse anti-EphA4 antibody were identified. This allowed for preparation of a humanized antibody comprising the CDR sequences of the mouse anti-EphA4 antibody in heavy chain variable region and light chain variable region.

Description

[0001] This application is a divisional application of the Chinese invention patent application 201680048438.4 (PCT application number PCT / JP2016 / 076102) with the filing date of September 6, 2016 and the title of the invention being "anti-EphA4 antibody". technical field [0002] The present invention relates to an antibody that binds to EphA4. Background technique [0003] EphA4 is a member of the receptor tyrosine kinase family. Ephrin (Ephrin) type A and type B are known as ligands of EphA4. Binding of EphA4 to ephrin as its ligand induces a de-adhesion signal. EphA4 is expressed in motor neurons and controls correct axon guidance during circuit formation in the spinal cord by expressing ephrin in the non-projection regions of motor neurons. [0004] Previous studies have suggested that functional inhibition of EphA4 is an effective treatment for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) or Alzheimer's disease, and spinal cord injuries mean...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C07K16/40
CPCC07K16/2866C07K16/40C07K2317/56C07K2317/76C07K2317/92C07K2317/24A61K2039/505C07K2317/33C07K2317/34C07K2317/52A61P25/28A61P21/02C07K2317/54C07K2317/55C12N15/62C07K2317/565C07K16/28
Inventor 田口良太今井俊夫井上英二山田章夫中谷亚季平山俊文尾野雄一伊藤俊介
Owner EISIA R&D MANAGEMENT CO LTD